Abstract. Seaweed contains large amounts of various arsenic compounds such as arsenosugars (AsSugs), but their relative toxicities have not yet been fully evaluated. A risk evaluation of dietary arsenic would be necessary. After developing an arsenic speciation analysis of wakame seaweed (Undaria pinnatifida), we conducted a wakame ingestion experiment using volunteers. Five volunteers ingested 300 g of commercial wakame after refraining from seafood for 5 days. Arsenic metabolites in the urine were monitored over a 5-day period after ingestion. Total arsenic concentration of the wakame seaweed was 34.3 ± 2.1 mg arsenic/kg (dry weight, n = 3). Two AsSugs, 3-[5′-deoxy-5′-(dimethyl-arsinoyl)-β-ribofuranosyloxy]-propylene glycol (AsSug328) and 3-[5′-deoxy-5′-(dimethyl-arsinoyl)-β-ribofuranosyl-oxy]-2-hydroxypropyl-2,3-dihydroxy-propyl phosphate (AsSug482) were detected, but arsenobetaine, dimethylarsinic acid (DMA), monomethylarsonic acid, and inorganic arsenics (iAs) were not detected. The major peak was AsSug328, which comprised 89% of the total arsenic. Approximately 30% of the total arsenic ingested was excreted in the urine during the 5-day observation. Five arsenic compounds were detected in the urine after ingestion, the major one being DMA, which comprised 58.1 ± 5.0% of the total urinary arsenic excreted over the 5 days. DMA was believed to be metabolized not from iAs but from AsSugs, and its biological half-time was approximately 13 h.
Introduction
The International Agency for Research on Cancer (IARC) has concluded that sufficient epidemiological evidence exists regarding the carcinogenicity of inorganic arsenic (iAs) in the human lung, skin, and urinary bladder (IARC, 2004) . The methylation of inorganic arsenic to monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA) has been demonstrated in humans and several mammalian species (Vahter, 2002) . These metabolites are less reactive with tissue constituents than iAs and are readily excreted in the urine. However, reactive intermediates of trivalent MMA and DMA (MMA III and DMA III ) produced in the metabolic processing of iAs in mammals may be responsible for the observed carcinogenic action (Yamanaka et al., 2004; Mizoi et al., 2005) . Therefore, the IARC has classified MMA and DMA into Group 2B and arsenobetaine (AsBe) and other organic arsenic compounds that are not metabolized in humans into Group 3 (IARC, 2010).
Seafood contains high levels of organoarsenic compounds such as AsBe, DMA, arsenocholine (AsCho), arsenosugars (AsSugs), and arsenolipids (AsLip) (Kirby et al., 2005; Taleshi et al., 2010) . AsSugs and AsLip are extensively metabolized to DMA (Francesconi et al., 2002; Schmeisser et al., 2006) . Therefore, as the intake of AsSugs, the major watersoluble organic arsenic compounds in seaweed, might pose a risk to human health, we attempted to measure urinary arsenic metabolites after seaweed ingestion by human volunteers.
Materials and Methods

Test seafood
Commercial dry wakame seaweed (Undaria pinnatifida) was purchased from a retail market in Chiba, Japan, and dipped in deionized water for 30 min prior to ingestion. 
Determination of total arsenic content in wakame seaweed
The total arsenic (T-As) content in wakame samples were analyzed with inductively coupled mass spectrometry (ICP-MS) using the dynamic reaction cell (DRC) mode (Elan DRCII ICP-MS; PerkinElmer SCIEX, Canada) after microwave acid digestion using a closed vessel system (Multiwave 3000; PerkinElmer SCIEX). The digested solution was measured using the standard addition method. Instrumental conditions for ICP-MS using the DRC mode were described in our earlier report (Shimoda et al., 2010) . The method was validated by analysis of DORM-3 (fish protein from the National Research Council of Canada) (certified T-As = 6.88 ± 0.88 µg/g; found T-As = 6.91 ± 0.26 µg/g, n = 3).
Extraction of arsenic from wakame seaweed
Prior to the ingestion experiment, we determined a suitable method to extract arsenic from seaweed. Methanol (50%) was used to extract arsenic compounds from the wakame seaweed. After cellulase treatment, we applied 3 physical procedures as extraction procedures: bead beating, ultrasonication, and shaking.
Ingestion of wakame seaweed and collection of urine samples
Five Japanese volunteers (2 men and 3 women; 21 ± 0.7 years old) ingested 300 g of wakame seaweed. The volunteers refrained from eating seafood 5 days prior to and during the course of the experiment. Arsenic metabolites in the urine were monitored before and up to 120 h after ingestion.
Analytical conditions
Arsenic species determination was performed using highperformance liquid chromatography (HPLC)-ICP-MS systems. We used a PRP-X100 (250 × 2.1 mm i.d.; Hamilton, USA) anion-exchange column to separate the arsenic compounds under the following conditions: mobile phase, 20 mM NH 4 HCO 3 (pH 9.0); flow rate, 0.2 mL/min; column temperature, 40°C; and injection volume, 10 µL. Detection of AsSugs in wakame seaweed was performed using MS/MS spectra and multiple reaction monitoring (MRM) using an amaZon SL ion trap tandem mass spectrometer (Bruker Daltonics, USA) with an electrospray ionization positive-ion mode. HPLC analytical conditions were the same as above. MRM was optimized to detect collision-induced dissociation fragmentations of the selected arsenic compounds (Table 1 ).
The molecular structures of the selected arsenic compounds are shown in Fig. 1 .
Results and Discussion
Determination of total arsenic and speciation analysis of wakame seaweed
The T-As concentration of dry wakame seaweed was 34.31 ± 2.10 µg As/g (n = 3). The arsenic contents extracted using the 3 methods are listed in Table 2 . Extraction using the bead beating method produced the highest yield and the extraction rate was 92%. This result indicates that >90% of arsenic compounds in dry seaweed are water-soluble organoarsenic compounds.
A chromatogram of the arsenic speciation analysis of wakame seaweed by HPLC-ICP-MS is depicted in Figure 2a . Three peaks were detected, but three peaks did not correlate with AsBe, DMA, MMA, trimethylarsine oxide, AsCho, or iAs. In HPLC-MS/MS analysis using MRM techniques, we detected AsSug328 and AsSug482, as shown in Figure 2b , but AsSug391, AsSug392, and AsSug408 were not detected. The major peak was AsSug328, which comprised 88.8% of T-As. 
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Arsenic in urine after wakame seaweed ingestion analyzed by HPLC-ICP/MS and HPLC-MS/MS
Five volunteers ingested 300 g of wakame seaweed each. The participants ingested 593.7 µg of arsenic in total, and 176.3 ± 65.2 µg of arsenic were detected in their urine, meaning that 30% of the ingested arsenic was excreted in the urine during the 5-day period. In contrast, when a male ingested water containing synthesized AsSug328 (1220 µg of arsenic), approximately 80% of the arsenic was excreted in urine over 4 days (Francesconi et al., 2002) . In our study, 5 volunteers ingested seaweed containing AsSug so that arsenic could be mainly excreted in the feces. The difference in the urinary excretion rate appeared to be due to the difference in intake method. A chromatogram of urinary arsenic speciation analysis is illustrated in Fig. 4 . Five compounds were detected; the major peak correlated with DMA, but other peaks did not correlate with the arsenics detected in wakame seaweed. DMA content was 58.1 ± 5.0% of T-As. Since AsSug328 comprises approximately 90% of the arsenic in wakame seaweed extract, it is presumed that a greater portion of the urinary DMA is AsSug328. These results agreed with those of an earlier report (Francesconi et al., 2002) in that the major metabolite was DMA since it constituted 67% of the total arsenic excreted following synthesized AsSug328 ingestion.
The maximum DMA excretion rate was 2.14 µg arsenic/h at 24 h after wakame seaweed intake. The DMA excretion rate before intake was 0.38 µg arsenic/h. Urinary DMA fell to the level before wakame intake 95 h after ingestion. The biological half-time (BHT) of DMA in urine is 13.4 h, a figure that was calculated using the values obtained from 24 to 44 h. Francesconi et al. (2002) also reported that the excretion rate peaked between 22 and 31 h, and the BHT of DMA was estimated to be 14 h. Our results accorded well with theirs, meaning that metabolism of AsSug does not have racial differences.
Conclusion
The total arsenic concentration of the wakame seaweed was 34.3 ± 2.1 µg arsenic/g. The best method for arsenic extraction from wakame seaweed was bead beating after cellulase treatment, the rate of which was 92%. Three peaks were detected in speciation analysis of the wakame seaweed, and 2 of them were the major peaks for AsSug328 and AsSug482. Five volunteers ingested 593.7 µg of arsenic, and 176.3 ± 65.2 µg of arsenic were detected in the urine over a 5-day period. The major metabolite, DMA, comprised approximately 60% of the detected arsenic. The BHT of DMA is estimated to be 13.4 h.
